text,labels
"There was a significant difference in the percent change in extent of late gadolinium enhancement , with the placebo group experiencing a larger increase ( +31 % 26 % with placebo vs.-23 % 45 % with losartan ; p = 0.03 ) .",3
"At day 42 , the ACPR was 99.27 % in the ASAQ group versus 100 % for both AL and DHAPQ groups , ( p = 0.36 ) .",3
"Overall , the current study suggests that RSB may be beneficial as an adjunct to therapy whereas PSB are potentially detrimental .",4
"A thorough assessment of shared decision-making preferences is an important component of recovery-oriented , client-centered care .",4
